H35.059
Retinal neovascularization, unspecified, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinal neovascularization refers to the abnormal growth of new blood vessels on the retina, the light-sensitive tissue at the back of the eye. This condition can affect either eye and is often linked to underlying eye diseases or systemic health issues. If left untreated, retinal neovascularization may lead to vision impairment or loss. Recognizing the signs and seeking appropriate medical care are vital steps in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Diabetic retinopathy: High blood sugar levels damage retinal blood vessels, prompting abnormal growth. Retinal vein occlusion: Blockage of retinal veins can reduce blood flow, encouraging new vessel formation as a response. Ocular ischemic syndrome: Poor blood supply to the eye causes the retina to produce new vessels in an attempt to improve oxygen delivery. Degenerative retinal disorders: Conditions such as retinopathy of prematurity or other ischemic retinal diseases. Inflammatory eye conditions: Chronic inflammation can stimulate abnormal vessel growth.
Key Symptoms: Sudden or gradual loss of vision Blurred or distorted vision Floaters or cobweb-like visual disturbances Dark patches or spots in the visual field In some cases, no noticeable symptoms until significant damage has occurred
Diagnostic & Treatment
Diagnosis Path: Diagnosis of retinal neovascularization typically involves a comprehensive eye examination, including:
Treatment Protocols: Managing retinal neovascularization involves addressing both the abnormal blood vessels and their underlying causes. Common treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is H35.059 a billable ICD-10 code?
Yes, H35.059 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.059?
Clinical documentation must specify the nature of Retinal neovascularization, unspecified, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference